Bitnomial Launches First-Ever U.S. Tezos (XTZ) Futures
"Tezos is resilient institutional-grade infrastructure, and now
"
Tezos is an open-source, self-upgrading blockchain built to last. Its on-chain governance lets stakeholders deliver protocol upgrades without disruptive hard forks, so applications stay stable while the network keeps getting faster and more capable. The original proof-of-stake protocol, Tezos now offers a sub-50ms latency EVM layer, a native data availability layer, and rollups to scale serious applications. Since 2018, Tezos has processed hundreds of millions of transactions representing billions of dollars in value, powering tokenized finance, gaming, and digital ownership for a global community.
The launch of XTZ futures expands Bitnomial's Crypto Complex®, which offers the broadest exposure to digital asset derivatives in the
XTZ futures are live for trading today for institutional and retail traders through Botanical, Bitnomial's retail trading platform. Bitnomial plans to launch XTZ perpetual futures and options in the future.
All Bitnomial futures contracts are offered by, and subject to the rules of, Bitnomial Exchange, LLC.
About Bitnomial, Inc.
Bitnomial, Inc., headquartered in
About Tezos
Tezos is an open-source and energy-efficient blockchain designed to empower institutions, developers, and businesses, and facilitate value transfer in a digital environment. It is designed for the scalable deployment of decentralized applications. As one of the first Proof of Stake blockchains, Tezos is globally supported and valued for its strong governance, long-term upgradability, and smart contract capabilities. For more information about Tezos, visit http://www.tezos.com.
Media Contact:
View original content to download multimedia:https://www.prnewswire.com/news-releases/bitnomial-launches-first-ever-us-tezos-xtz-futures-302678408.html
SOURCE Bitnomial
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nakamoto reduces debt by $45 million, authorizes $25 million share buyback
- Diana Shipping urges Genco shareholders to vote against poison pill
- Rein Therapeutics expands Phase 2 trial to UK, enrolls 16 patients
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
BitcoinSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share